Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Database III: Genetic tests in development

Database of genetic tests in development

Table III-2: Test (by other types of cancer)

Return to Contents

Name Other Cancer Developer Data Source
AFP-L3   Wako LexisNexis
Alpha Catenin     EDRN
APC     EDRN
BAT-26     EDRN
Bladder cancer test Bladder ChondroGene, MSKCC LexisNexis
BladderChek Bladder M.D. Anderson C.C, Matritech Inc. LexisNexis
Breast Cancer Detection   IMI International CHI
Breast Cancer Outcome Prediction Test   Epigenomics, Roche Diagnostics LexisNexis
Cancer antigen 72-4 Stomach Roche Diagnostics Roche Diagnostics
CDK family   M.D. Anderson LexisNexis
CDKN24     EDRN
CDP/Cux   DiagnoCure, McGill U. LexisNexis
CellSearch   Immunicon, Veridex. Quest Diagnostics LexisNexis, CHI
CeMines CellCorrect Lab   CeMines LexisNexis
Chromosome 8q gain     ClinicalTrials.gov
c-Kit pharmDx GIST DakoCytomation LexisNexis
Colorectal cancer test   Microprevention Tests LexisNexis
Colorectal gene panel   Quest diagnostics LexisNexis
Colorectalert   IMI Medical LexisNexis, CHI
Conversion Analysis   GMP Companies, Cleveland Clinic LexisNexis
Cox-2 RNA     EDRN
cPSA     FDA
CupPrint Tumor of unknown origin Agendia LexisNexis
Cyfra 21-1   Roche Diagnostics Roche Diagnostics
Cytokeratin 20   Roche Diagnostics Roche Diagnostics
CytoVision   Applied Imaging Corp LexisNexis
des-gamma carboxyprothrombin     EDRN
DNA methylation Kidney   Google news, CHI
DNA methylation   Orion Genomics, Methexis, Roche, Sequenom LexisNexis, CHI
EEF1A2     CISTI
EGFR Cervical, endometrial   EDRN, ClinicalTrials.gov, CHI
EGFR   Genzyme, DFCI, MGH LexisNexis
EPCA   Tessera, Johns Hopkins U LexisNexis
eTag   ViroLogic, AstraZeneca LexisNexis, CHI
Genomic Test     ClinicalTrials.gov
GOS     EDRN
GSTM1     Google news
GSTP1     EDRN, Google news
Her-1, Her-2, Her-3, Her-4   Roche Diagnostics Roche Diagnostics
HLA-E Gliomas   Google news
HP1alpha     CISTI
HPV test Cervical Diagene, GenoID LexisNexis
HPV test Cervical Roche Diagnostics Roche Diagnostics
IGF-II Cervical, endometrial   EDRN
IMI breast cancer test   IMI Medical LexisNexis
Immunocyt/ uCyt Bladder DiagnoCure, Gen-Probe LexisNexis
Iressa test   U of Tokyo, AstraZeneca LexisNexis
Key2   Exagen LexisNexis
K-ras     EDRN
Leukemia Affymetrix Chip   Roche Diagnostics Roche Diagnostics
Leukemia blood test   Genzyme CHI
Lung cancer test   Cangen Biotech, Olympus LexisNexis
Lung cancer test   Cleveland Clinic LexisNexis
LungAlert   IMI Medical LexisNexis
Lysophopholipids     ClinicalTrials.gov
M2-PK   Giessen U LexisNexis
MammaPrint   Agendia, Transbig, Molecular Profiling Institute LexisNexis
Matrix metalloproeinases     ClinicalTrials.gov
Melanoma inhibiting antigen Melanoma Roche Diagnostics Roche Diagnostics
Melastatin Melanoma   ClinicalTrials.gov
MESOMARK Mesothelioma Fujirebio Diagnostics LexisNexis
MGMT     EDRN
Microsatelitte Analysis Bladder   ClinicalTrials.gov
MLH1     EDRN
MN protein     ClinicalTrials.gov
MSA Bladder   EDRN, ClinicalTrials.gov
MSA analysis Bladder Cangen Biotech LexisNexis
NAF test   Power3 LexisNexis
NMP179 Cervical Matritech Inc. LexisNexis
NMP22 Bladder   FDA/ CHI
NMP35   Matritech Inc. LexisNexis
NMP48   Matritech Inc. LexisNexis
NMP66   Matritech Inc. LexisNexis, CHI
OncoVue breast cancer risk test   Tm Bioscience/ Intergenetics LexisNexis, CHI
Ovacheck   Quest, LabCorp, Correlogic LexisNexis
Ovarian cancer biomarker test   Ciphergen Biosystems, Johns Hopkins LexisNexis
Ovarian cancer test   Yale U LexisNexis
Ovarian cancer test   Beth Israel Deaconess Medical Center LexisNexis
Ovarian pap test     ClinicalTrials.gov
p16, p15, p14 deletions All   ClinicalTrials.gov
p202     CISTI
p53 Affymetrix Chip Others Roche Diagnostics Roche Diagnostics
Prostate 63     CLIA
Prostate biomarkers   Health Discovery Corporation/Stanford U CHI
Prostate Cancer Blood Test   Correlogic CHI
Protein Profile test     ClinicalTrials.gov
PSA testing   Qualigen, Healthtronics LexisNexis
PSMA   Cytogen CHI
PSP94   Procyon, Medicorp LexisNexis
PTEN tumor suppressor     CISTI
PyloriProbe   AMDL LexisNexis
Recaf   Abbot, BioCurex LexisNexis
RhoC GTPase     CISTI
S100 Melanoma Roche Diagnostics Roche Diagnostics
SELDI-TOF-MS     EDRN
SurePath Cervical Tripath Imaging LexisNexis
Telomerase Bladder Roche Diagnostics Roche Diagnostics
TGF genes     Google news
TUO test Tumor of unknown origin US LABS LexisNexis
uPM3   DiagnoCure, Gen-Probe LexisNexis
Urinary plasminogen activator     ClinicalTrials.gov
Urine test for cervical cancer Cervical U. Washington LexisNexis
VEGF   Quest LexisNexis
WISP3     CISTI

Return to Contents
Proceed to Next Section

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care